510 related articles for article (PubMed ID: 15777951)
41. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
42. The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system.
Furman MI; Nurden P; Berndt MC; Nurden AT; Benoit SE; Barnard MR; Ofosu FA; Michelson AD
Thromb Haemost; 2000 Nov; 84(5):897-903. PubMed ID: 11127874
[TBL] [Abstract][Full Text] [Related]
43. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
[TBL] [Abstract][Full Text] [Related]
44. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
[TBL] [Abstract][Full Text] [Related]
45. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
46. Glycoprotein Ib-binding protein from the venom of Deinagkistrodon acutus--cDNA sequence, functional characterization, and three-dimensional modeling.
Chen YL; Tsai KW; Chang T; Hong TM; Tsai IH
Thromb Haemost; 2000 Jan; 83(1):119-26. PubMed ID: 10669165
[TBL] [Abstract][Full Text] [Related]
47. Structure and function of snake venom toxins interacting with human von Willebrand factor.
Matsui T; Hamako J
Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
[TBL] [Abstract][Full Text] [Related]
48. Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib.
Shin Y; Morita T
Biochem Biophys Res Commun; 1998 Apr; 245(3):741-5. PubMed ID: 9588185
[TBL] [Abstract][Full Text] [Related]
49. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
O'Brien JR; Etherington MD
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
[TBL] [Abstract][Full Text] [Related]
50. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
51. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
[TBL] [Abstract][Full Text] [Related]
52. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
Kasirer-Friede A; Frojmovic MM
Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
[TBL] [Abstract][Full Text] [Related]
53. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation.
Miyake T; Nomura S; Komiyama Y; Miyazaki Y; Kagawa H; Masuda M; Takahashi H; Fujimura Y; Ikeda Y; Fukuhara S
Thromb Haemost; 1997 Aug; 78(2):902-9. PubMed ID: 9268193
[TBL] [Abstract][Full Text] [Related]
54. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
South V; Searfoss GH; French S; Cheadle C; Murray E; Howk R; Jaye M; Ricca GA
Thromb Haemost; 1995 Jan; 73(1):144-50. PubMed ID: 7537918
[TBL] [Abstract][Full Text] [Related]
55. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
Peng Y; Berndt MC; Cruz MA; López JA
Blood; 2004 Dec; 104(13):3971-8. PubMed ID: 15319289
[TBL] [Abstract][Full Text] [Related]
56. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
Tanoue K; Jung SM; Yamamoto N; Yamazaki H
Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
[TBL] [Abstract][Full Text] [Related]
57. Role of glycoprotein Ibalpha mobility in platelet function.
van der Wal DE; Verhoef S; Schutgens RE; Peters M; Wu Y; Akkerman JW
Thromb Haemost; 2010 May; 103(5):1033-43. PubMed ID: 20216992
[TBL] [Abstract][Full Text] [Related]
58. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
[TBL] [Abstract][Full Text] [Related]
59. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
Chang MC; Lin HK; Peng HC; Huang TF
Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
[TBL] [Abstract][Full Text] [Related]
60. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding.
Fujimura Y; Miyata S; Nishida S; Miura S; Kaneda M; Yoshioka A; Fukui H; Katayama M; Tuddenham EG; Usami Y
Thromb Haemost; 1992 Oct; 68(4):464-9. PubMed ID: 1280375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
